A genetic variant of the CAPN10 gene in Mexican subjects with dyslipidemia is associated with increased HDL-cholesterol concentrations after the consumption of a soy protein and soluble fiber dietary portfolio;Una variante genÉtica del gen capn10 en sujetos mexicanos con dislipidemia se asocia con un aumento de las concentraciones de colesterol hdl despuÉs del consumo de un portafolio dietario de de soya y fibra soluble

Nutricion Hospitalaria

Volumn 30, Issue 3, 2014, Pages 671-677

  Guevara Cruz, Martha ^a   Torres, Nimbe ^a   Tovar, Armando R ^a   Tejero, M Elizabeth ^b   Castellanos Jankiewicz, Ashley ^b,c   Bosque Plata, del Laura ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c Universidad del Mayab   (Mexico)

Author keywords

Calpain 10; Dietary portfolio; Dyslipidemia; Hypercholesterolemic; Polymorphism

Indexed keywords

CALPAIN; CALPAIN 10; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN;

ADULT; BLOOD; DIET THERAPY; DIETARY FIBER; DYSLIPIDEMIA; FEMALE; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; MALE; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY;

ADULT; CALPAIN; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIETARY FIBER; DYSLIPIDEMIAS; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MEXICO; PROSPECTIVE STUDIES; SOYBEAN PROTEINS;

EID: 84908152802     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.30.3.7611     Document Type: Article

References (33)

1. Aguilar-Salinas CA, Olaiz G, Valles V, Torres JM, Gomez Perez FJ, Rull JA, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res 2001; 42:1298-307.
2. Inamori T, Goda T, Kasezawa N, Yamakawa-Kobayashi K. The combined effects of genetic variation in the SIRT1 gene and dietary intake of n-3 and n-6 polyunsaturated fatty acids on serum LDL-C and HDL-C levels: a population based study. Lipids Health Dis 2013; 12:4.
3. Torres N, Guevara-Cruz M, Granados J, Vargas-Alarcon G, Gonzalez-Palacios B, Ramos-Barragan VE, et al. Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects. Nutr Res 2009; 29:728-35.
4. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993-2000.
5. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
6. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79:8-15.
7. Guevara-Cruz M, Tovar AR, Larrieta E, Canizales-Quinteros S, Torres N. Increase in HDL-C concentration by a dietary portfolio with soy protein and soluble fiber is associated with the presence of the ABCA1R230C variant in hyperlipidemic Mexican subjects. Mol Genet Metab 2010; 101:268-72.
8. Acuna-Alonzo V, Flores-Dorantes T, Kruit JK, Villarreal-Molina T, Arellano-Campos O, Hunemeier T, et al. A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans. Hum Mol Genet 2010; 19:2877-85.
9. Aguilar-Salinas CA, Gomez-Perez FJ, Rull J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex 2010; 52(Suppl 1):S44-53.
10. Cheverud JM, Fawcett GL, Jarvis JP, Norgard EA, Pavlicev M, Pletscher LS, et al. Calpain-10 is a component of the obesity- related quantitative trait locus Adip1. J Lipid Res 2010; 51:907-13.
11. Suzuki K, Hata S, Kawabata Y, Sorimachi H. Structure, activation, and biology of calpain. Diabetes 2004; 53(Suppl 1):S12-8.
12. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, et al. A genome-wide search for human non-insulin- dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13:161-6.
13. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26:163-75.
14. Shima Y, Nakanishi K, Odawara M, Kobayashi T, Ohta H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta 2003; 336:89-96.
15. Wu B, Takahashi J, Fu M, Cheng H, Matsumura S, Taniguchi H. Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population. Diabetes Res Clin Pract 2005; 68:155-61.
16. Chen SF, Lu XF, Yan WL, Huang JF, Gu DF. Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chin Med J (Engl) 2007; 120:2218-23.
17. Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL, et al. SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 2002; 51:231-7.
18. Carlsson E, Fredriksson J, Groop L, Ridderstrale M. Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J Clin Endocrinol Metab 2004; 89:3601-5.
19. Perez-Martinez P, Delgado-Lista J, Garcia-Rios A, Ferguson JF, Gulseth HL, Williams CM, et al. Calpain-10 interacts with plasma saturated fatty acid concentrations to influence insulin resistance in individuals with the metabolic syndrome. Am J Clin Nutr 2011; 93:1136-41.
20. Paul DS, Harmon AW, Winston CP, Patel YM. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J 2003; 376:625-32.
21. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012; 380:572-80.
22. del Bosque-Plata L, Aguilar-Salinas CA, Tusie-Luna MT, Ramirez- Jimenez S, Rodriguez-Torres M, Auron-Gomez M, et al. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metab 2004; 81:122-6.
23. Saez ME, Gonzalez-Sanchez JL, Ramirez-Lorca R, Martinez- Larrad MT, Zabena C, Gonzalez A, et al. The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population. PLoS One 2008; 3:e2953.
24. Nauck M, Marz W, Wieland H. New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol. Clin Chem 1998; 44:1443-51.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
26. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
27. Fryirs MA, Barter PJ, Appavoo M, Tuch BE, Tabet F, Heather AK, et al. Effects of high-density lipoproteins on pancreatic beta- cell insulin secretion. Arterioscler Thromb Vasc Biol 2010; 30:1642-8.
28. Song Y, You NC, Hsu YH, Sul J, Wang L, Tinker L, et al. Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women. Hum Mol Genet 2007; 16:2960-71.
29. Cohen J. Statistical power analysis for the behavioral sciences (2nd ed). Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.
30. Munguia-Miranda C, Sanchez-Barrera RG, Hernandez-Saavedra D, Cruz-Lopez M. (Dyslipidemia prevalence and its relationship with insulin resistance in a population of apparently healthy subjects). Salud Publica Mex 2008; 50:375-82.
31. Ye SQ, Kwiterovich PO, Jr. Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 2000; 72:1275S-84S.
32. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR, et al. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol 2005; 19:213-24.
33. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009; 41:56-65.